We report here that transforming growth factor-beta 2 (TGFβ2) autocrine upregulation plays a central role in the early adaptive omics reprogramming and drug escape in EGFR-mutant NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.